Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach

PURPOSE: Telotristat etiprate, a tryptophan hydroxylase inhibitor, was previously evaluated in a Phase II randomized, placebo-controlled clinical trial in patients with carcinoid syndrome (CS) and diarrhea not adequately controlled by octreotide. The objective of the current study was to characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhorn, Heather L., Kulke, Matthew H., O’Dorisio, Thomas, Yang, Qi M., Jackson, Jessica, Jackson, Shanna, Boehm, Kristi A., Law, Linda, Kostelec, Jacqueline, Auguste, Priscilla, Lapuerta, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047308/
https://www.ncbi.nlm.nih.gov/pubmed/27041406
http://dx.doi.org/10.1016/j.clinthera.2016.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047308/
https://www.ncbi.nlm.nih.gov/pubmed/27041406
http://dx.doi.org/10.1016/j.clinthera.2016.03.002

Ejemplares similares